UOC
XAGE

UBS O'Connor’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

UBS O'Connor’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-49,500
Closed -$15.3M – 640
2023
Q2 		$15.3M Hold
49,500
– – 0.32% 48
2023
Q1 		$15.1M Buy
+49,500
New +$14.9M 0.36% 46
2022
Q4 		– Sell
-49,500
Closed -$14.5M – 377
2022
Q3 		$14.5M Hold
49,500
– – 0.16% 75
2022
Q2 		$14.4M Buy
+49,500
New +$14.4M 0.15% 74
2022
Q1 		– Sell
-49,500
Closed -$14.4M – 257
2021
Q4 		$14.4M Hold
49,500
– – 0.14% 68
2021
Q3 		$14.4M Buy
+49,500
New +$14.4M 0.11% 78

Other funds holding XAGE

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS O'Connor's XAGE Position: Q3 2023 in Review

UBS O'Connor sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 49,500 shares — an estimated $15.3M sold.

UBS O'Connor first reported a position in XAGE in Q3 2021 and held it in 6 quarters. The position peaked at $15.3M in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • UBS O'Connor reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 49,500 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $15.3M.
  • UBS O'Connor first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • UBS O'Connor's Longevity Health Holdings, Inc. Common Stock position peaked at $15.3M in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.